Related Experiment Videos
[Role of polyol-myoinositol metabolic changes in the pathogenesis of diabetic macro-angiopathy]
Sheng Li Ke Xue Jin Zhan [Progress in Physiology]
|October 1, 1990
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
[Research progress of toluene exposure and its health hazards].
Zhonghua lao dong wei sheng zhi ye bing za zhi = Zhonghua laodong weisheng zhiyebing zazhi = Chinese journal of industrial hygiene and occupational diseases·2026
Photoluminescence and magnetism integrated multifunctional black phosphorus probes through controllable PO bond orbital hybridization.
Physical chemistry chemical physics : PCCP·2021
[The apoptosis of K562 cells induced by IL-3 and hydroxyurea cooperatively].
Shi yan sheng wu xue bao·2003
[Studies on DNA-protein interactions in the HS3 of the human beta-LCR].
Shi yan sheng wu xue bao·2002
Function of GATA transcription factors in hydroxyurea-induced HEL cells.
Cell research·2002
[Nitric Oxide Signaling Pathway and Vascular Activity].
Sheng li ke xue jin zhan [Progress in physiology]·2018
[The Regulation Effects of Carbon Monoxide in Cardiovascular Systems].
Sheng li ke xue jin zhan [Progress in physiology]·2018
[Research Progress in the Neurobiological Effects of Hydrogen Sulfide].
Sheng li ke xue jin zhan [Progress in physiology]·2018
[Adipocytic Endogenous Hydrogen Sulfide-Function,Regulation and Diseases].
Sheng li ke xue jin zhan [Progress in physiology]·2018
[Role Ofhydrogen Sulfide on Inflammatory Immune Disorders in Cardiovascular Diseases].
Sheng li ke xue jin zhan [Progress in physiology]·2018
[Research Advances in Hydrogen Sulfide and Diabetes Mellitus as Well as Diabetic Complications].
Sheng li ke xue jin zhan [Progress in physiology]·2018
Medicine-Food Homology Bioactives for Polyendocrine Metabolic Ovarian Syndrome: Multi-Target Mechanisms and Functional Food Translation.
Molecules (Basel, Switzerland)·2026
The MASLD-Heart Axis: Biological Mechanisms, Cardiac Remodeling, and Clinical Implications.
Pharmaceuticals (Basel, Switzerland)·2026